Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-11-02 Sale |
2020-11-04 5:31 pm |
Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO |
70,000 | $39 | $2,729,939 | 698,861 (Direct) |
View |
| 2020-11-02 Sale |
2020-11-04 5:30 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $37.21 | $212,110 | 150,211 (Direct) |
View |
| 2020-10-16 Sale |
2020-10-20 4:52 pm |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
37,851 | $38.16 | $1,444,206 | 306,521 (Direct) |
View |
| 2020-10-13 Sale |
2020-10-13 5:43 pm |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
1,649 | $40 | $65,960 | 145,917 (Direct) |
View |
| 2020-10-01 Sale |
2020-10-05 5:12 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $34.54 | $196,901 | 155,911 (Direct) |
View |
| 2020-09-08 Sale |
2020-09-10 6:21 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
47,919 | $30 | $1,437,570 | 340,423 (Direct) |
View |
| 2020-09-01 Sale |
2020-09-03 6:35 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $27.74 | $158,113 | 209,530 (Direct) |
View |
| 2020-08-28 Sale |
2020-08-31 6:04 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
2,081 | $30 | $62,430 | 215,230 (Direct) |
View |
| 2020-08-03 Sale |
2020-08-04 4:59 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $24.73 | $140,943 | 217,311 (Direct) |
View |
| 2020-07-16 Sale |
2020-07-17 6:02 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
1,900 | $25.06 | $47,614 | 223,011 (Direct) |
View |
| 2020-07-07 Sale |
2020-07-09 5:43 pm |
Stoke Therapeutics Inc. | STOK | Walker Robin A. Chief Legal Officer, CCO & Sec |
941 | $22.5 | $21,173 | 0 (Direct) |
View |
| 2020-07-07 Sale |
2020-07-09 5:41 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
913 | $22.41 | $20,457 | 0 (Direct) |
View |
| 2020-07-01 Sale |
2020-07-02 6:08 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
3,800 | $23.15 | $87,968 | 224,911 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-11-02 Exercise |
2020-11-04 5:31 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO |
70,000 | $4.48 | 698,861 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 5:31 pm |
N/A 2029-03-18 |
Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO |
70,000 | $0 | 698,861 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 5:30 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $2.19 | 150,211 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 5:30 pm |
N/A 2018-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $0 | 150,211 (Direct) |
View |
| 2020-10-19 Exercise |
2020-10-20 4:52 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
1,503 | $2.19 | 306,521 (Direct) |
View |
| 2020-10-16 Exercise |
2020-10-20 4:52 pm |
N/A 2028-04-02 |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
37,851 | $0 | 306,521 (Direct) |
View |
| 2020-10-16 Exercise |
2020-10-20 4:52 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
36,348 | $0.6 | 306,521 (Direct) |
View |
| 2020-10-13 Exercise |
2020-10-13 5:43 pm |
N/A 2028-04-02 |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
1,649 | $0 | 145,917 (Direct) |
View |
| 2020-10-13 Exercise |
2020-10-13 5:43 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev |
1,649 | $0.6 | 145,917 (Direct) |
View |
| 2020-10-01 Exercise |
2020-10-05 5:12 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $2.19 | 155,911 (Direct) |
View |
| 2020-10-01 Exercise |
2020-10-05 5:12 pm |
N/A 2018-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $0 | 155,911 (Direct) |
View |
| 2020-09-08 Exercise |
2020-09-10 6:21 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
47,919 | $2.19 | 340,423 (Direct) |
View |
| 2020-09-08 Exercise |
2020-09-10 6:21 pm |
N/A 2018-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
47,919 | $0 | 340,423 (Direct) |
View |
| 2020-09-01 Exercise |
2020-09-03 6:35 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $2.19 | 209,530 (Direct) |
View |
| 2020-09-01 Exercise |
2020-09-03 6:35 pm |
N/A 2018-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $0 | 209,530 (Direct) |
View |
| 2020-08-28 Exercise |
2020-08-31 6:04 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
2,081 | $2.19 | 215,230 (Direct) |
View |
| 2020-08-28 Exercise |
2020-08-31 6:04 pm |
N/A 2018-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
2,081 | $0 | 215,230 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-04 4:59 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $2.19 | 217,311 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-04 4:59 pm |
N/A 2018-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
5,700 | $0 | 217,311 (Direct) |
View |
| 2020-07-16 Exercise |
2020-07-17 6:02 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
1,900 | $2.19 | 223,011 (Direct) |
View |
| 2020-07-16 Exercise |
2020-07-17 6:02 pm |
N/A 2018-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
1,900 | $0 | 223,011 (Direct) |
View |
| 2020-07-01 Exercise |
2020-07-02 6:08 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
3,800 | $2.19 | 224,911 (Direct) |
View |
| 2020-07-01 Exercise |
2020-07-02 6:08 pm |
N/A 2018-12-12 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
3,800 | $0 | 224,911 (Direct) |
View |